Edition:
United States

Teva Pharmaceutical Industries Ltd (TEVA.N)

TEVA.N on New York Stock Exchange

13.84USD
17 Nov 2017
Change (% chg)

$1.05 (+8.21%)
Prev Close
$12.79
Open
$12.73
Day's High
$13.96
Day's Low
$12.72
Volume
5,879,607
Avg. Vol
4,366,438
52-wk High
$39.41
52-wk Low
$10.85

Select another date:

Wed, Nov 15 2017

BRIEF-Teva announces prescription copay savings program for generic Gleevec tablets in the U.S.

* Teva announces prescription copay savings program for generic Gleevec® tablets in the United States Source text for Eikon: Further company coverage:

Allergan to sell a quarter of its Teva stake in first quarter of 2018

NEW YORK Allergan Plc said on Monday it will sell just under a quarter of its roughly 10 percent stake in Israel's Teva Pharmaceutical Industries during the first quarter of 2018, as it starts to unwind its position in the struggling generic drugmaker.

Allergan to sell a quarter of its Teva stake in Q1 2018

NEW YORK, Nov 13 Allergan Plc said on Monday it will sell just under a quarter of its roughly 10 percent stake in Israel's Teva Pharmaceutical Industries during the first quarter of 2018, as it starts to unwind its position in the struggling generic drugmaker.

Mylan raises forecast on strength of generic Copaxone

Mylan NV on Monday raised its full-year forecast and expects sales from its recently approved version of Teva's blockbuster multiple sclerosis treatment Copaxone to offset declining revenue from its EpiPen emergency allergy injector.

UPDATE 3-Mylan raises forecast on strength of generic Copaxone

* Raises lower end of 2017 revenue, adjusts earnings forecasts

Billionaire Blavatnik weighs big share purchase in Teva Pharm: reports

JERUSALEM Billionaire businessman Len Blavatnik is looking to buy a significant stake in debt-ridden Israeli drugmaker Teva Pharmaceutical Industries , according to Israeli media reports.

UPDATE 1-Billionaire Blavatnik weighs big share purchase in Teva Pharm-reports

JERUSALEM, Nov 5 Billionaire businessman Len Blavatnik is looking to buy a significant stake in debt-ridden Israeli drugmaker Teva Pharmaceutical Industries, according to Israeli media reports.

Billionaire Blavatnik weighs big share purchase in Teva Pharm-reports

JERUSALEM, Nov 5 Billionaire businessman Len Blavatnik is looking to buy a significant stake in debt-ridden Israeli drugmaker Teva Pharmaceutical Industries, according to Israeli media reports.

Teva shares topple on profit warning, uncertain future

JERUSALEM Teva Pharmaceutical Industries , the world's biggest generic medicine maker, came under investor and market pressure on Thursday after saying it would miss 2017 profit forecasts.

UPDATE 3-Teva shares topple on profit warning, uncertain future

* New CEO says debt reduction a key priority (Releads, adds chairman/CFO comment, updates share reaction)

Select another date: